Carfilzomib

Carfilzomib

Carfilzomib (PR-171) is a second-generation, irreversible proteasome inhibitor targeting the β5 subunit (IC50 = 5.2 nM) and β5i subunit (IC50 = 14 nM), inducing apoptosis in multiple myeloma and other cancers. Reagent grade, for research use only.

Molecular structure of the compound BP-43632
    • Unit
    • Price
    • Qty
    • 50 MG
    • $130.00
    • 100 MG
    • $230.00
    • 250 MG
    • $430.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire